IPP Bureau
GSK’s RSV vaccine ‘Arexvy’ receives positive European Medicines Agency’s CHMP opinion for adults aged 50-59
By IPP Bureau - July 30, 2024
Decision on EU marketing authorisation for this population expected by September 2024
Dr. Reddy's receives positive CHMP opinion from EMA for its proposed Rituximab biosimilar
By IPP Bureau - July 30, 2024
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Pfizer Ltd. posts Q1 FY25 PAT at Rs. 150.71 Cr
By IPP Bureau - July 30, 2024
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
GSK and Flagship partner to discover novel medicines and vaccines
By IPP Bureau - July 30, 2024
GSK and Flagship to jointly fund up to $150 million upfront
Aarti Drugs posts Q1 FY25 PAT lower at Rs. 33.3 Cr
By IPP Bureau - July 30, 2024
India reiterates commitment to adolescents on launch of ‘Economic Case for Investment in the Well-being of Adolescents in India’ report
By IPP Bureau - July 29, 2024
Report highlights significant improvements in adolescent well-being in India
India established Comprehensive Lactation Management Centres for feeding low birth weight babies in ICUs
By IPP Bureau - July 29, 2024
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Steps taken by India for preparedness against future pandemics
By IPP Bureau - July 29, 2024
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr
By IPP Bureau - July 29, 2024
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
USFDA completes inspection at Biocon Biologics’ facilities in Bengaluru
By IPP Bureau - July 29, 2024
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Briefs: Indoco Remedies and Alembic Pharmaceuticals
By IPP Bureau - July 29, 2024
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
Max Healthcare CMD Abhay Soi recognised as one of the highest individual tax payers in India
By IPP Bureau - July 27, 2024
Abhay Soi, who had paid an income tax of approximately Rs 400 crore in the assessment year 2023-24 has been recognised as the “Top Individual tax payers having gross tax payable > Rs 10 Lakhs"
USAID and Takeda launch dengue prevention campaign
By IPP Bureau - July 27, 2024
Campaign launched to spread awareness regarding dengue prevention and control
Mankind Pharma to acquire 100% stake in Bharat Serums from Advent for Rs. 13,630 Cr
By IPP Bureau - July 26, 2024
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
